These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. A semiautomated measure of whole-brain atrophy in multiple sclerosis. Bermel RA; Sharma J; Tjoa CW; Puli SR; Bakshi R J Neurol Sci; 2003 Apr; 208(1-2):57-65. PubMed ID: 12639726 [TBL] [Abstract][Full Text] [Related]
6. A reassessment of the plateauing relationship between T2 lesion load and disability in MS. Sormani MP; Rovaris M; Comi G; Filippi M Neurology; 2009 Nov; 73(19):1538-42. PubMed ID: 19794123 [TBL] [Abstract][Full Text] [Related]
7. A two-year study using cerebral gray matter volume to assess the response to fingolimod therapy in multiple sclerosis. Yousuf F; Dupuy SL; Tauhid S; Chu R; Kim G; Tummala S; Khalid F; Weiner HL; Chitnis T; Healy BC; Bakshi R J Neurol Sci; 2017 Dec; 383():221-229. PubMed ID: 29146095 [TBL] [Abstract][Full Text] [Related]
8. Brain lesion location and clinical status 20 years after a diagnosis of clinically isolated syndrome suggestive of multiple sclerosis. Dalton CM; Bodini B; Samson RS; Battaglini M; Fisniku LK; Thompson AJ; Ciccarelli O; Miller DH; Chard DT Mult Scler; 2012 Mar; 18(3):322-8. PubMed ID: 21878451 [TBL] [Abstract][Full Text] [Related]
9. Extent of cerebellum, subcortical and cortical atrophy in patients with MS: a case-control study. Ramasamy DP; Benedict RH; Cox JL; Fritz D; Abdelrahman N; Hussein S; Minagar A; Dwyer MG; Zivadinov R J Neurol Sci; 2009 Jul; 282(1-2):47-54. PubMed ID: 19201003 [TBL] [Abstract][Full Text] [Related]
10. An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis. Kim G; Tauhid S; Dupuy SL; Tummala S; Khalid F; Healy BC; Bakshi R J Neurol; 2016 Mar; 263(3):531-8. PubMed ID: 26754005 [TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis: hyperintense lesions in the brain on nonenhanced T1-weighted MR images evidenced as areas of T1 shortening. Janardhan V; Suri S; Bakshi R Radiology; 2007 Sep; 244(3):823-31. PubMed ID: 17690319 [TBL] [Abstract][Full Text] [Related]
12. HLA-DRB1*1501, -DQB1*0301, -DQB1*0302, -DQB1*0602, and -DQB1*0603 alleles are associated with more severe disease outcome on MRI in patients with multiple sclerosis. Zivadinov R; Uxa L; Bratina A; Bosco A; Srinivasaraghavan B; Minagar A; Ukmar M; Benedetto Sy; Zorzon M Int Rev Neurobiol; 2007; 79():521-35. PubMed ID: 17531857 [TBL] [Abstract][Full Text] [Related]
13. Gray matter atrophy in multiple sclerosis: a longitudinal study. Fisher E; Lee JC; Nakamura K; Rudick RA Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561 [TBL] [Abstract][Full Text] [Related]
14. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status. Masek M; Vaneckova M; Krasensky J; Danes J; Havrdova E; Hrebikova T; Seidl Z Neuro Endocrinol Lett; 2008 Aug; 29(4):461-6. PubMed ID: 18766142 [TBL] [Abstract][Full Text] [Related]
15. Brain MRI Predicts Worsening Multiple Sclerosis Disability over 5 Years in the SUMMIT Study. Bakshi R; Healy BC; Dupuy SL; Kirkish G; Khalid F; Gundel T; Asteggiano C; Yousuf F; Alexander A; Hauser SL; Weiner HL; Henry RG; J Neuroimaging; 2020 Mar; 30(2):212-218. PubMed ID: 31994814 [TBL] [Abstract][Full Text] [Related]
16. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study. Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104 [TBL] [Abstract][Full Text] [Related]
17. Exploring the effect of glatiramer acetate on cerebral gray matter atrophy in multiple sclerosis. AbdelRazek MA; Tummala S; Khalid F; Tauhid S; Jalkh Y; Khalil S; Hurwitz S; Zurawski J; Bakshi R J Neurol Sci; 2023 Jan; 444():120501. PubMed ID: 36481574 [TBL] [Abstract][Full Text] [Related]